Alexion Pharmaceuticals (ALXN) PT Lowered to $127 at Morgan Stanley
Get Alerts ALXN Hot Sheet
Price: $182.01 --0%
Rating Summary:
10 Buy, 25 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
10 Buy, 25 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison lowered the price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $127.00 (from $131.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Boston Scientific (BSX) PT Raised to $83 at Stifel
- Lynas Corporation Limited (LYC:AU) (LYSDY) PT Raised to AUD7 at Canaccord Genuity
- Goldman Sachs Upgrades Bank Central Asia Tbk (BBCA:IJ) (PBCRY) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!